1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Immunohistochemistry Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Immunohistochemistry Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Incidences of Chronic and Infectious Diseases
- 5.1.2 Increasing Geriatric Population
- 5.1.3 Increasing R&D Investments by Biotechnology & Biopharmaceutic mpanie
5.2 Market Opportunities
- 5.2.1 Development Opportunities in Emerging Countries
5.3 Future Trends
- 5.3.1 Increasing Acceptance of Automation in Immunohistochemistry
5.4 Impact of Drivers and Restraints
6. North America Immunohistochemistry Market Regional Analysis
6.1 North America Immunohistochemistry Market Overview
6.2 North America Immunohistochemistry Market Revenue 2019-2028 (US$ Million)
6.3 North America Immunohistochemistry Market Forecast Analysis
7. North America Immunohistochemistry Market Analysis – by Application
7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Diagnostics: North America Immunohistochemistry Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Drug Testing
- 7.2.1 Overview
- 7.2.2 Drug Testing: North America Immunohistochemistry Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Immunohistochemistry Market Analysis – by Product
8.1 Antibodies
- 8.1.1 Overview
- 8.1.2 Antibodies: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Equipment
- 8.2.1 Overview
- 8.2.2 Equipment: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Reagents
- 8.3.1 Overview
- 8.3.2 Reagents: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Kits
- 8.4.1 Overview
- 8.4.2 Kits: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Immunohistochemistry Market Analysis – by End User
9.1 Hospitals and Diagnostic Laboratories
- 9.1.1 Overview
- 9.1.2 Kits: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Research Institutes
- 9.2.1 Overview
- 9.2.2 Kits: North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Immunohistochemistry Market – North America Analysis
10.1 North America
- 10.1.1 North America Immunohistochemistry Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Immunohistochemistry Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Immunohistochemistry Market Breakdown, by Application
- 10.1.1.1.2 US: North America Immunohistochemistry Market Breakdown, by Product
- 10.1.1.1.3 US: North America Immunohistochemistry Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Immunohistochemistry Market Breakdown, by Application
- 10.1.1.2.2 Canada: North America Immunohistochemistry Market Breakdown, by Product
- 10.1.1.2.3 Canada: North America Immunohistochemistry Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Immunohistochemistry Market Breakdown, by Application
- 10.1.1.3.2 Mexico : North America Immunohistochemistry Market Breakdown, by Product
- 10.1.1.3.3 Mexico : North America Immunohistochemistry Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Immunohistochemistry Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abcam plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Bio SB
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BIO-RAD LABORATORIES INC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Cell Signaling Technology, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Danaher
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 MERCK KGaA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 PerkinElmer Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 THERMO FISHER SCIENTIFIC INC.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights